| 151 |
Definitive salvage chemotherapy for the treatment of refractory/relapsed non-Hodgkin lymphoma, a single center experience |
2018 |
| 152 |
Definitive salvage chemotherapy for the treatment of refractory/relapsed non-Hodgkin lymphoma, a single center experience |
2018 |
| 153 |
Early Predictors of Acute Pancreatitis Related
In-Hospital Mortality: How Practical Are They? |
2018 |
| 154 |
Hematopoietic Recovery after in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant-Effects of Major ABO Incompatibility, CMV Viremia and Acute Gvhd |
2018 |
| 155 |
Impact of CD39 expression on CD4+ T lymphocytes and 6q deletion on outcome of patients with chronic lymphocytic leukemia |
2018 |
| 156 |
Impact of CD39 expression on CD4+ T lymphocytes and 6q deletion on outcome of patients with chronic lymphocytic leukemia |
2018 |
| 157 |
Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post‐transplant |
2018 |
| 158 |
Long-Term Acid Suppressive Therapy among Naïve
Patients with Mycobacterium Tuberculosis Infection |
2018 |
| 159 |
Lower transcranial Doppler flow velocities in sickle cell anemia patients on hydroxyurea: myth or fact |
2018 |
| 160 |
Lower transcranial Doppler flow velocities in sickle cell anemia patients on hydroxyurea: myth or fact |
2018 |
هل لديك سؤال ؟
